# Draft Genome Sequences of Two Pseudomonas aeruginosa Multidrug-Resistant Clinical Isolates, PAL0.1 and PAL1.1

Teddy Grandjean, Rémi Le Guern, Claire Duployez, Karine Faure, Eric Kipnis, Rodrigue Dessein

► To cite this version:

Teddy Grandjean, Rémi Le Guern, Claire Duployez, Karine Faure, Eric Kipnis, et al. Draft Genome Sequences of Two Pseudomonas aeruginosa Multidrug-Resistant Clinical Isolates, PAL0.1 and PAL1.1. Microbiology Resource Announcements, 2018, 7 (17), pp.e00940-18. 10.1128/MRA.00940-18. hal-02566183

HAL Id: hal-02566183

https://hal.science/hal-02566183

Submitted on 31 Jul 2021

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_2.png" /></figure>

# Draft Genome Sequences of Two *Pseudomonas aeruginosa* Multidrug-Resistant Clinical Isolates, PAL0.1 and PAL1.1

Teddy Grandjean,ª Rémi Le Guern,ª,b Claire Duployez,ª,b Karine Faure,ª,b,c Eric Kipnis,ª,b,c,d Rodrigue Desseinª,b

**ABSTRACT** *Pseudomonas aeruginosa* infections are challenging due to intrinsic and acquired resistance mechanisms. We report here the draft genome sequences of two multidrug-resistant strains—PAL0.1, isolated from the airways of an intensive care unit (ICU) patient with ventilator-associated pneumonia, and PAL1.1, isolated from blood cultures of an ICU patient with sepsis.

Pseudomonas aeruginosa is one of the most common nosocomial pathogens, responsible for acute infections such as ventilator-associated pneumonia and infections in immunocompromised hosts, such as burn patients. Due to increasing multidrug resistance (MDR), P. aeruginosa is among the top-priority pathogens according to the World Health Organization (1). In addition to intrinsic and acquired antibiotic resistance mechanisms (decreased outer membrane permeability, enzymatic antibiotic deactivation, and efflux pumps), P. aeruginosa forms biofilms that decrease exposure to antimicrobials. Treating MDR P. aeruginosa infections is increasingly challenging and requires new therapeutic approaches. Two representative MDR clinical strains related to the well-described PAO1 and PA14 phylogenetic clades were isolated from patients in the Lille University Teaching Hospital (CHU Lille, France)—PAL1.1, isolated from the airways of an intensive care unit (ICU) patient with ventilator-associated pneumonia, and PAL0.1, isolated from blood cultures of an ICU patient with sepsis. Both strains were isolated from blood cultures using the Virtuo automated system (bioMérieux, Marcy-l'Étoile, France) and were identified by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (Bruker Daltonics, Inc., Billerica, MA). The complete genome sequences of these strains were determined in order to assess lectin-specific bacterial adhesion inhibiting glycosylated calixarenes against multidrug-resistant (MDR) *Pseudomonas aeruginosa* strains.

Genomic DNA from *P. aeruginosa* strains PAL0.1 and PAL1.1 was extracted after an overnight culture using a QIAamp DNA minikit (Qiagen, Hilden, Germany). Libraries were prepared using the Nextera XT DNA Library prep kit (Illumina, San Diego, CA), followed by paired-end (2 × 150-bp) sequencing on an Illumina HiSeq platform. Genome coverage was about 650× for each isolate. Paired reads were filtered, and Nextera adapters were removed using Trimmomatic (2). Processed reads were de novo assembled with the Unicycler pipeline on a Galaxy server version 0.4.1.1 using default settings (3). Annotation was performed using the NCBI Prokaryotic Genome Annotation Pipeline version 4.5. The genome lengths are 7,040,354 bp and 6,780,687 bp with G+C contents of 65.87% and 66.04% for PAL0.1 and PAL1.1, respectively. The assembly reported 131 contigs with an *N*<sub>50</sub> value of 202,317 bp for PAL0.1 and 108 contigs with an *N*<sub>50</sub> value of 222,705 bp for PAL1.1.

The PAL0.1 genome annotation consists of 6,736 coding sequences (CDSs) and 65

Received 2 July 2018 Accepted 4 October 2018 Published 1 November 2018

**Citation** Grandjean T, Le Guern R, Duployez C, Faure K, Kipnis E, Dessein R. 2018. Draft genome sequences of two *Pseudomonas aeruginosa* multidrug-resistant clinical isolates, PAL0.1 and PAL1.1. *Microbiol Resour Announc* 7:e00940-18. https://doi.org/10.1128/MRA.00940-18.

**Editor** Frank J. Stewart, Georgia Institute of Technology

**Copyright** © 2018 Grandjean et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

Address correspondence to Rodrigue Dessein, rodrigue.dessein@chru-lille.fr.

<footnote>ªHost-Pathogens Translational Research Group, Faculty of Medicine of Lille, University of Lille Nord de France, Lille, France</footnote>

<footnote>ᵇInstitut de Microbiologie, CHU Lille, Lille, France</footnote>

<footnote>ᶜUnité de Maladies Infectieuses, CHU Lille, Lille, France</footnote>

<footnote>ᵈService de Réanimation Chirurgicale, CHU Lille, Lille, France</footnote>
<figure><img src="image_3.png" /></figure>

structural RNAs. Detection of acquired antimicrobial resistance genes using ResFinder version 3.0 (4) found 2 aminoglycoside resistance genes [aacA29 and aph(3')-llb], 3 beta-lactam resistance genes (blaOXA-50, blaPAO, and blaVIM-2), the fosfomycin resistance gene fosA, and the sulfonamide resistance gene sul1.

The PAL1.1 genome annotation consists of 6,479 CDSs and 68 structural RNAs. Detection of acquired antimicrobial resistance genes using ResFinder version 3.0 found 3 aminoglycoside resistance genes [aph(3')-llb, ant(2')-la, and aadA11], 2 beta-lactam resistance genes (blaOXA-50 and blaPAO), the fosfomycin resistance gene fosA, the sulfonamide resistance gene sul1, the phenicol resistance gene catB7, and the trim-ethoprim resistance gene dfrB1.

Multilocus sequence typing (MLST) was performed using MLST version 2.0 from the Center for Genomic Epidemiology (5). PAL0.1 (PAO1 clade) is a Verona integrin-encoded metallo-beta-lactamase (VIM-2)-producing strain that belongs to the sequence type 111 (ST-111), a clonal strain responsible for nosocomial infection epidemics worldwide (6, 7). PAL1.1 (PA14 clade) shares an acquired resistance genotype commonly observed worldwide among clinical *P. aeruginosa* strains (8) belonging to ST-2613.

**Data availability.** The whole-genome shotgun project of PAL0.1 and PAL1.1 has been deposited in DDBJ/EMBL/GenBank under the accession no. QFRL00000000 and QFRM00000000, respectively. The SRA accession no. is SRP155966.

## ACKNOWLEDGMENT

This work was supported by the "14ème appel à projets du fonds unique interministériel," project ANTI-PYO, under grant no. AAP14-F1211009V.

## REFERENCES

1. Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N, WHO Pathogens Priority List Working Group. 2018. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18:318–327. https://doi.org/10.1016/S1473-3099(17)30753-3.

2. Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114–2120. https://doi.org/10.1093/bioinformatics/btu170.

3. Wick RB, Judd LM, Gorrie CL, Holt KE. 2017. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 13:e1005595.

4. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640–2644. https://doi.org/10.1093/jac/dks261.

5. Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, Jelsbak L, Sicheritz-Pontén T, Ussery DW, Aarestrup FM, Lund O. 2012. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol 50:1355–1361. https://doi.org/10.1128/JCM.06094-11.

6. Oliver A, Mulet X, López-Causapé C, Juan C. 2015. The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist Updat 21-22: 41–59. https://doi.org/10.1016/j drup.2015.08.002.

7. Mulet X, Cabot G, Ocampo-Sosa AA, Domínguez MA, Zamorano L, Juan C, Tubau F, Rodríguez C, Moyà B, Peña C, Martínez-Martínez L, Oliver A, Spanish Network for Research in Infectious Diseases (REIPI). 2013. Biological markers of Pseudomonas aeruginosa epidemic high-risk clones. Antimicrob Agents Chemother 57:5527–5535. https://doi.org/10.1128/AAC.01481-13.

8. Berrazeg M, Jeannot K, Ntsogo Enguéné VY, Broutin I, Loeffert S, Fournier D, Plésiat P. 2015. Mutations in β-lactamase AmpC increase resistance of Pseudomonas aeruginosa isolates to antipseudomonal cephalosporins. Antimicrob Agents Chemother 59:6248–6255. https://doi.org/10.1128/AAC.00825-15.